Literature DB >> 28148948

The immuno-oncology race: myths and emerging realities.

Stephen Cavnar1, Pedro Valencia2, Jesse Brock1, Judith Wallenstein3, Valery Panier1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28148948     DOI： 10.1038/nrd.2016.279

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

Review 1.  Immune Checkpoint PD-1/PD-L1: Is There Life Beyond Antibodies?

Authors:  Markella Konstantinidou; Tryfon Zarganes-Tzitzikas; Katarzyna Magiera-Mularz; Tad A Holak; Alexander Dömling
Journal:  Angew Chem Int Ed Engl       Date:  2018-02-23       Impact factor: 15.336

2.  Commentary on Perez et al.: How to create a 21st century adverse event reporting system.

Authors:  Elad Sharon
Journal:  Clin Trials       Date:  2017-03-26       Impact factor: 2.486

Review 3.  Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper.

Authors:  Alastair Greystoke; Andrea Luciani; Fabio Gomes; Melisa Wong; Nicolò Matteo Luca Battisti; Tiana Kordbacheh; Mandy Kiderlen
Journal:  Br J Cancer       Date:  2020-07-22       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.